Interferon Alpha 2a Downregulates Vegf Expression Through Pi3 Kinase and Map Kinase Signaling Pathways

Wei-Zhong Wu,Hui-Chuan Sun,Yue-Fang Shen,Jie Chen,Lu Wang,Zhao-You Tang,George Iliakis,Kang-Da Liu
DOI: https://doi.org/10.1007/s00432-004-0615-2
2004-01-01
Journal of Cancer Research and Clinical Oncology
Abstract:An earlier report demonstrated that interferon alpha (IFN-α) inhibited tumor growth and recurrence in an MHCC97 xenograft model in nude mice by suppressing tumor angiogenesis rather than by inhibiting tumor cell proliferation. However, the underlying molecular mechanism was not fully elucidated. In this study, we demonstrated that IFN-α 2a could downregulate VEGF expression both in mRNA and in protein levels, as well as downregulating HIF-1α mRNA expression in MHCC97 cells in vitro. A cDNA micro array analysis followed by Northern and Western blot analysis revealed that PI3 kinase and MAP kinase signaling pathways might be inhibited by IFN-α 2a. Blocking the function of IFN-α receptor with a specific peptide could eliminate the inhibitory effects of IFN-α 2a on VEGF expression. In addition, wortmannin and PD098059, respective inhibitors of the PI3 kinase and the MAP kinase signaling pathways, when used independently or in combination, could also downregulate the VEGF synthesis and secretion in a similar pattern of IFN-α 2a. These observations may lead to the conclusion that IFN-α 2a could suppress VEGF synthesis and secretion by downregulating HIF-1α expression, via inhibition of the PI3 kinase and/or the MAP kinase signaling pathways.
What problem does this paper attempt to address?